Fat loss, glucose control, mitochondrial metabolism, and metabolic optimization
Showing all 5 results
GLP-2/T is a dual GIP and GLP-1 receptor agonist developed to improve glucose tolerance and adiposity management. It mimics the body’s natural incretin signaling to enhance insulin sensitivity, suppress appetite, and reduce body-fat mass.
BUY 5 save 5%
BUY 10 save 10%Â
GLP-2/T is a dual GIP and GLP-1 receptor agonist developed to improve glucose tolerance and adiposity management. It mimics the body’s natural incretin signaling to enhance insulin sensitivity, suppress appetite, and reduce body-fat mass.
BUY 5 save 5%
BUY 10 save 10%Â
GLP-3/R is a next-generation metabolic peptide designed as a triple-agonist for the GLP-1, GIP, and glucagon receptors. Early human trials suggest profound effects on glucose regulation, appetite control, and body-weight reduction.
By targeting three key hormonal pathways simultaneously, GLP-3R represents an evolution beyond single-agonist incretin therapies.
BUY 5 save 5%
BUY 10 save 10%Â
GLP-3/R is a next-generation metabolic peptide designed as a triple-agonist for the GLP-1, GIP, and glucagon receptors. Early human trials suggest profound effects on glucose regulation, appetite control, and body-weight reduction.
By targeting three key hormonal pathways simultaneously, GLP-3R represents an evolution beyond single-agonist incretin therapies.
BUY 5 save 5%
BUY 10 save 10%Â
GLP-3/R is a next-generation metabolic peptide designed as a triple-agonist for the GLP-1, GIP, and glucagon receptors. Early human trials suggest profound effects on glucose regulation, appetite control, and body-weight reduction.
By targeting three key hormonal pathways simultaneously, GLP-3R represents an evolution beyond single-agonist incretin therapies.
BUY 5 save 5%
BUY 10 save 10%Â
Notifications
Join the AminoWave Labs community and unlock exclusive savings on premium wellness peptides.
By subscribing you agree to receive marketing emails. Unsubscribe anytime.
